Axios Pro Rata: 🦣 Colossal scoop

1. Key Themes

Deeptech & Biotech Attracting Massive Capital at Unprecedented Valuations

Colossal Biosciences is seeking to raise at a valuation of $20–30 billion, doubling from its January 2025 valuation of $10.2 billion in roughly 18 months. The article frames this as emblematic of a broader wave: "Colossal's raise comes amid a deeptech boom, as AI drives interest in cutting edge computing, energy technology, and longevity medicines." The transition from pre-revenue to revenue-generating status in a single funding cycle is a meaningful signal that investors are rewarding scientific proof points with steep re-ratings.

De-extinction Science as a Platform for Adjacent Markets

Investors aren't backing Colossal merely as a novelty — they see foundational commercial utility across multiple verticals. As the article notes, "Investors believe its work could be foundational in pharmaceuticals, climate change reversal, and longevity." The company has also spun off two businesses — Breaking (plastic degradation) and Form Bio (DNA analytics software) — demonstrating how core genomic R&D can generate independent commercial ventures.

Restaurant IPO Market Opening Up

Jersey Mike's Subs filing to list at a $6.7–$7.8 billion market cap is being watched as a bellwether: "There's hope that if the public market digests the offering well a feast of restaurant IPOs could follow." The fact that Inspire Brands (Dunkin', Arby's) filed confidentially for an IPO in May adds to the sense that PE-backed consumer brand exits are queuing up. For investors, this is a signal that public appetite for consumer/franchise businesses may be re-opening.

AI Infrastructure Consolidation Accelerating

Two notable AI-related liquidity events appear in this edition: SAP acquiring Prior Labs (a German frontier AI company) for over €1 billion, and OpenRouter (an AI model routing company last valued at $1.3B) in discussions to sell to a larger tech company "that could value it in the billions of dollars." The pattern: infrastructure-layer AI companies are becoming acquisition targets for large enterprise software and tech players seeking to embed AI routing and intelligence capabilities.

Materials Discovery Emerging as a High-Conviction VC Bet

CuspAI, a U.K.-based materials discovery startup, raised $450M in Series B at a $2.6 billion valuation, led by Kleiner Perkins and NEA with participation from Jeff Bezos and John Doerr. The scale of the round and the caliber of investors signals that AI-powered materials science is graduating from niche to mainstream investment theme — sitting at the intersection of AI and physical-world application (energy, manufacturing, defense).

2. Contrarian Perspectives

Colossal at $20–30B May Be More Hype Than Science The most obvious counterpoint to Colossal's soaring valuation is that its core mission remains scientifically contested. "Critics argue that its recreations are more PR stunt than real scientific advancement, with some arguing that its revival of extinct species could have ecological risks." Given that the company was pre-revenue as recently as early 2025, a $20–30B valuation implies investors are pricing in speculative future markets (artificial wombs, pharmaceutical platforms, government contracts) rather than current cash flows. Investors should stress-test whether the multiple is justified by platform value or narrative momentum.

The Topgolf Playbook Is Being Replicated — But the Market May Be Saturated Bluestone Equity Partners' $55M investment in Poolhouse — a pool hall startup from the creators of Topgolf and Puttshack — bets that the "eatertainment" format has another successful iteration left. The founders have produced two hits, but the broader experiential leisure sector has seen significant capital destruction post-COVID. The article offers no counterargument here, but investors should assess whether consumer discretionary spending can support yet another premium social gaming venue concept, particularly with gas prices hitting $4/gallon and geopolitical uncertainty rising.

Government Genetic Vaults as a Revenue Bridge for Biotech Moonshots Colossal is doing work "for the U.S. government and Dubai's Museum of the Future on vaults of genetic material from endangered species." This is a non-obvious business model insight: government and sovereign contracts for conservation infrastructure may be quietly funding the company's more ambitious (and speculative) de-extinction goals. For biotech founders, this suggests that packaging moonshot science into near-term government services contracts can be a viable path to revenue before the core thesis matures.

3. Companies Identified

Colossal Biosciences

Description: De-extinction and synthetic biology company pursuing the resurrection of the dire wolf, woolly mammoth, and South Island giant Moa; has spun off Breaking (plastic degradation) and Form Bio (DNA analytics)
Why mentioned: Headline scoop — raising at $20–30B valuation, doubling from $10.2B in early 2025; transition from pre-revenue to revenue-generating
Quote: "Investors believe its work could be foundational in pharmaceuticals, climate change reversal, and longevity."

Jersey Mike's Subs

Description: Blackstone-backed sandwich chain filing for IPO
Why mentioned: Priced at $21–$25/share targeting $6.7–$7.8B market cap; seen as a potential catalyst for a wave of restaurant IPOs
Quote: "There's hope that if the public market digests the offering well a feast of restaurant IPOs could follow."

CuspAI

Description: U.K.-based AI-powered materials discovery startup
Why mentioned: Raised $450M Series B at $2.6B valuation, backed by Kleiner Perkins, NEA, Jeff Bezos, and John Doerr — one of the largest deeptech rounds in this issue
Quote: Listed as raising "$450m in Series B funding valuing it at $2.6b"

OpenRouter

Description: AI model routing company, last valued at $1.3B by investors including CapitalG
Why mentioned: In discussions to sell to a larger tech company "that could value it in the billions of dollars," per The Information — a notable AI infrastructure exit in progress
Quote: "OpenRouter, an AI model routing company, has discussed a sale to a bigger tech company that could value it in the billions of dollars."

Prior Labs

Description: German-founded frontier AI company, backed by Balderton Capital
Why mentioned: Acquired by SAP for over €1 billion — a significant enterprise AI M&A signal
Quote: "SAP acquired Prior Labs, a German-founded frontier AI company for over €1b."

Inspire Brands

Description: Owner of Dunkin' and Arby's
Why mentioned: Filed confidentially for IPO in May 2026, supporting the thesis of a restaurant IPO pipeline opening
Quote: "Dunkin' and Arby's owner Inspire Brands filed confidentially for an IPO in May."

Poolhouse

Description: Pool hall startup founded by the creators of Topgolf and Puttshack
Why mentioned: Received $55M from Bluestone Equity Partners; represents the "eatertainment" bet from proven serial founders
Quote: "Bluestone Equity Partners led a $55m investment in Poolhouse, a pool hall startup founded by Steve and Dave Jolliffe, the creators of Topgolf and Puttshack."

General Bio

Description: SF-based developer of oral GLP-1s and other peptides
Why mentioned: Raised $7.4M seed; represents continued investor interest in oral GLP-1 delivery as a near-term pharmaceutical opportunity
Quote: Listed as "an SF-based developer of oral GLP-1s and other peptides"

AMR Resources Acquisition

Description: SPAC targeting critical minerals companies; raised $250M
Why mentioned: Signals continued institutional interest in critical minerals via the SPAC structure
Quote: "A blank check company seeking a critical minerals company, raised $250m."

RapidPulse

Description: Miami-based medical tech company focused on aspiration therapy for acute ischemic stroke
Why mentioned: Raised $48M Series B with Medtronic participation — strategic backing from a major medtech player validates the technology direction
Quote: Listed as "a Miami-based aspiration medical tech company for acute ischemic stroke, raised $48m in Series B funding. Medtronic [participated]."

4. People Identified

Ben Lamm

Description: CEO of Colossal Biosciences
Why mentioned: Made a bold public timeline claim — "expects to create an artificial womb for mammals within a year" — that, if realized, would open the door to human reproductive applications and dramatically expand Colossal's addressable market
Quote: "CEO Ben Lamm told Rolling Stone in May that he expects to create an artificial womb for mammals within a year, opening the door to human usage."

Steve and Dave Jolliffe

Description: Serial experiential leisure entrepreneurs; founders of Topgolf and Puttshack
Why mentioned: Now backing Poolhouse, their third venue concept, with $55M in PE backing — cited as a case study in repeat founder pattern recognition
Quote: "Poolhouse, a pool hall startup founded by Steve and Dave Jolliffe, the creators of Topgolf and Puttshack."

Norman Chen

Description: Formerly of Balyasny Asset Management; newly appointed Managing Director at the U.S. International Development Finance Corp. (DFC), heading ventures and growth practice
Why mentioned: Represents movement of sophisticated institutional investment talent into government development finance — potentially significant for emerging market and deeptech deal flow
Quote: "Norman Chen, formerly of Balyasny, joined the U.S. International Development Finance Corp. as managing director heading the ventures and growth practice."

Matthew Fitzgerald

Description: Former CFO of Sandfire Resources; now leading AMR Resources Acquisition SPAC
Why mentioned: Brings sector-specific operating credentials to a critical minerals SPAC at a moment of heightened strategic interest in mineral supply chains
Quote: "Former CFO of Sandfire Resources Matthew Fitzgerald leads the SPAC."

5. Operating Insights

Spin-offs as a Commercialization Strategy for Deep Science Companies Colossal has deliberately spun out its non-core but commercially viable capabilities into independent companies — Breaking (plastic degradation) and Form Bio (DNA analytics software). This is an operationally savvy move: it unlocks separate capital formation, creates cleaner valuation stories for each business, and prevents the core mission (de-extinction) from being obscured by adjacent revenue streams. Founders building in deep science should evaluate whether IP or technology developed for the primary mission has standalone commercial value that could be separately financed.

Quote: "The company has spun off two businesses, plastic degradation company Breaking and DNA analytics software company Form Bio."

Revenue Generation as a Re-Rating Catalyst Colossal's valuation essentially doubled — from $10.2B to $20–30B — in part because the company "now has some revenue (it was pre-revenue when it raised its last round)." For founders in capital-intensive science and deeptech, even modest initial revenue can dramatically shift investor narrative from "speculative bet" to "validated platform." The implication: prioritizing early commercial contracts (e.g., government vaults, licensing) alongside R&D is not just a survival tactic — it's a valuation lever.

Quote: "The company now has some revenue (it was pre-revenue when it raised its last round), sources say."

6. Overlooked Insights

Sovereign and Government Funds as Active Co-Investors in Deeptech Britain's Sovereign AI Venture Fund and the Abu Dhabi Investment Authority (ADIA) both appear in this edition — the former as a co-investor in CuspAI's $450M round, and the latter as a selling stockholder in Jersey Mike's IPO with an 8.5% stake. Sovereign capital is not merely passive — it is actively participating in Series B deeptech rounds alongside top-tier VCs. Founders and fund managers should increasingly view sovereign wealth vehicles as a viable and strategic LP/co-investor class, particularly in AI, materials, and biotech.

Quote (CuspAI): "Britain's Sovereign AI Venture Fund [participated]." (Quote, ADIA): "Abu Dhabi Investment Authority [is] selling a stake worth $82.5 million" and "holding 8.5%" post-offering.

Critical Minerals SPACs Are Back AMR Resources Acquisition raised $250M as a blank check company explicitly targeting critical minerals — a sector with direct national security and EV supply chain implications. The SPAC structure had fallen out of favor post-2021, but its reappearance in a strategically sensitive sector suggests that when the acquisition target universe is narrow and specialized, SPACs retain utility as a capital formation vehicle. This is worth watching as a potential indicator of renewed SPAC activity in hard-asset and resource sectors.

Quote: "AMR Resources Acquisition, a blank check company seeking a critical minerals company, raised $250m."